Search
budesonide/formoterol (Symbicort)
Indications:
- asthma & reactive airway disease, maintenace therapy
- maintenance therapy for COPD (2nd line therapy)
Dosage:
- 2 puffs BID
- use 160/4.5 for COPD [3]
Inhalation: 80/4.5 & 160/4.5 mg budesonide/mg formoterol
Storage: good for 90 days after opening [4]
Adverse effects:
- oral candidiasis
- dysphonia
- bronchitis
- headache
- muscle spasms
Notes: Manufacturer: AstraZeneca
General
LABA glucocorticoid combination
References
- Prescriber's Letter 14(2): 2007
New drugs approved by the FDA in 2006
Detail-Document#: 2302213
(subscription needed) http://www.prescribersletter.com
- Prescriber's Letter 14(8): 2007
Symbicort (Budesonide/Formoterol) Inhalation Aerosol
Detail-Document#: 230812
(subscription needed) http://www.prescribersletter.com
- Prescriber's Letter 16(4): 2009
Symbicort (Budesonide/Formoterol) for COPD
Detail-Document#: 250126
(subscription needed) http://www.prescribersletter.com
- Prescriber's Letter 16(9): 2009
COMMENTARY: Shortened Expiration Dating of Some Inhalation
Products
PATIENT HANDOUT: Tips for Correct Use of Inhalers
Detail-Document#: 250903
(subscription needed) http://www.prescribersletter.com
Components
budesonide (Rhinocort, Pulmicort, Turbuhaler, Flexhaler, Entocort EC, Uceris, Cortiment, Eohilia)
formoterol (Foradil, Perforomist)